Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

about

Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

Item

http://www.wikidata.org/entity/Q55275094

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@en

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@nl

type

Item

label

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@en

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@nl

prefLabel

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@en

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@nl

P1476

Intravitreal anti-VEGF agents, ...... occlusion: preliminary report.

@en

P2093

Cheng Li

http://www.w3.org/2001/XMLSchema#string

Qi-Shan Zheng

http://www.w3.org/2001/XMLSchema#string

Qian-Ying Gao

http://www.w3.org/2001/XMLSchema#string

Wan-Wen Shao

http://www.w3.org/2001/XMLSchema#string

Xiao-Bing Qian

http://www.w3.org/2001/XMLSchema#string

Xiao-Xiao Feng

http://www.w3.org/2001/XMLSchema#string

Yong-Guang Yuan

http://www.w3.org/2001/XMLSchema#string

Yu-Jie Li

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia

Defining response to anti-VEGF therapies in neovascular AMD

EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Long-term effect of early intervention with single intravitreal injection of bevacizumab followed by panretinal and macular grid photocoagulation in central retinal vein occlusion (CRVO) with macular edema: a pilot study.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration.

Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.

Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

P304

429-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18240/IJO.2018.03.13

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29600177

http://www.w3.org/2001/XMLSchema#string

P921

Light Coagulation

P932

5861233

http://www.w3.org/2001/XMLSchema#string